However, findings from the sebaceous tumours we could test suggest biallelic somatic MLH1 mutations are a more likely cause of MLH1/PMS2-deficiency than somatic MLH1 hypermethylation. The gene discussed is MLH1; the disease is sebaceous gland neoplasm.